Hepatitis B: reflections on the current approach to antiviral therapy.
about
KASL clinical practice guidelines: management of chronic hepatitis BNTCP and beyond: opening the door to unveil hepatitis B virus entryChronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions.Pros and Cons of Peginterferon Versus Nucleos(t)ide Analogues for Treatment of Chronic Hepatitis B.Peginterferon alpha-based therapy for chronic hepatitis B focusing on HBsAg clearance or seroconversion: a meta-analysis of controlled clinical trials.Antiviral activity of Bay 41-4109 on hepatitis B virus in humanized Alb-uPA/SCID miceAntiviral treatment of chronic hepatitis B virus (HBV) infectionsCombination treatment in HBeAg-negative chronic hepatitis B.Mathematical modeling of triphasic viral dynamics in patients with HBeAg-positive chronic hepatitis B showing response to 24-week clevudine therapy.Serum GP73, a marker for evaluating progression in patients with chronic HBV infections.High-throughput matrix-assisted laser desorption ionization-time of flight mass spectrometry as an alternative approach to monitoring drug resistance of hepatitis B virus.New approaches in the management of chronic hepatitis B: role of tenofovir.Long-term virological outcome in chronic hepatitis B patients with a partial virological response to entecavirGenotypic resistance profiles in Chinese patients with chronic hepatitis B virus infection and the efficacy of nucleoside analog rescue therapy.HBV and HCV therapy.Recent advances in the management of chronic hepatitis B.Models for predicting hepatitis B e antigen seroconversion in response to interferon-α in chronic hepatitis B patientsKASL Clinical Practice Guidelines: Management of chronic hepatitis B.Eight-year seroprevalence of HBV, HCV and HIV in Diyarbakir training and research hospital.Efficacy of consensus interferon in treatment of HbeAg-positive chronic hepatitis B: a multicentre, randomized controlled trial.MicroRNA-939 restricts Hepatitis B virus by targeting Jmjd3-mediated and C/EBPα-coordinated chromatin remodeling.Inhibitory effect of emodin and Astragalus polysaccharide on the replication of HBV.Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL).Then and now: the progress in hepatitis B treatment over the past 20 years.Lessons from HIV therapy applied to viral hepatitis therapy: summary of a workshop.End points of therapy in chronic hepatitis B.Fitness and infectivity of drug-resistant and cross-resistant hepatitis B virus mutants: why and how is it studied?On-treatment monitoring of chronic hepatitis B virus infection: an Asian-Pacific perspective.Is chronic hepatitis B being undertreated in the United States?Hepatitis B virus resistance to antiviral drugs: where are we going?Future aspects of therapy for hepatitis B virus infection: value of surrogate markers, innovative therapy, and global collaboration.Review article: current antiviral therapy of chronic hepatitis B.Optimal management of chronic hepatitis B patients with treatment failure and antiviral drug resistance.Interferon-alpha plus adefovir combination therapy versus interferon-alpha monotherapy for chronic hepatitis B treatment: A meta-analysis.Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B.Addition of nucleoside analogues to peg-IFNα-2a enhances virological response in chronic hepatitis B patients without early response to peg-IFNα-2a: a randomized controlled trial.The SIRT1 inhibitor, nicotinamide, inhibits hepatitis B virus replication in vitro and in vivo.Anti-hepatitis B virus activity in vitro of combinations of tenofovir with nucleoside/nucleotide analogues.In Vitro Enzymatic and Cell Culture-Based Assays for Measuring Activity of HBV RNaseH Inhibitors.Therapeutic potential of a combined hepatitis B virus surface and core antigen vaccine in patients with chronic hepatitis B.
P2860
Q26752475-7B0D239C-BB33-4086-BE10-1A7F52CC12CBQ26999712-2B5D0B88-6E5F-44F3-8E2F-F39EDDE3C688Q33718958-334E2659-56FF-4D4E-B245-CA0018380492Q33819124-35C2E7B7-A542-443F-BD61-F56E84381AF9Q33926126-3C715D7D-12F9-42BE-B8CD-7B3D18263CB0Q34097557-81DAC578-1CC2-43EF-95C9-1A601724D1EFQ34223779-4FD73E57-5DD5-404D-A899-D405C920E226Q34391476-657B0A13-C479-4FFE-B4A6-20BC21EE1A54Q34500227-DDDDD8CD-D067-44D6-ABDD-FE956D163158Q34589487-2F4F8604-08E2-4843-88B6-951D26D0B89BQ34997985-34D44540-9688-424D-A6BF-5443501CFCA8Q35026531-82807B44-EE3B-48D3-BA91-694905F05E35Q35152633-0A48ACD2-5F4A-4F4A-B2AA-ACDD9A777D7DQ35186029-5BB227A1-84C9-4B0F-A8D8-0B8BD6DBADC6Q35259824-55AFA336-2956-4286-951E-FABEF5D1F413Q35582461-C8B32468-E4D4-4FA3-9169-66009FD75BA3Q35594289-F853B3B0-23F2-4AE2-8D48-B464648AAD40Q36153966-510A30EC-F873-4491-8ABF-8CF5E5642701Q37177002-86D303BC-8AA6-465F-A07E-7C5EFC17581EQ37274078-7DF0E7A7-31DB-421B-9733-3BFBA83835EAQ37363959-95D14E0E-5247-4D3F-A6A0-003935D5BCB8Q37461164-3F301E20-ACAC-46F7-BE5A-61E584A08860Q37577568-1A42DD69-E092-4310-855D-1850605E44FDQ37581346-A2FE9BD1-C149-4FAC-A100-B3D10DB849ABQ37678183-2A7E74CA-7DB4-4B07-BD2D-2296C3F1015BQ37688129-36FCCBCB-7D77-4C16-ACE6-3893589DDC3BQ37762114-A4831DD4-F8E6-452F-A4F5-1F9D084C57A5Q37764961-877A09C3-1953-44F5-902B-B28256BDA753Q37818488-0351473D-0F3A-46AD-B31F-8CF94B8BCBEFQ37825963-06B5591F-9D7C-404A-80D7-60FD4C38FCE9Q37869826-958D9736-DB74-46F5-980C-9C1132F155ECQ37943006-6834C093-ECDE-43E5-A65C-C5D1F74343F5Q38071396-BFA3ABF0-79D2-46B4-9610-C092E84EC2C2Q38077311-0009F260-4EF1-4850-A701-ED01CBB5DAC9Q38475543-1773299C-605A-423D-B346-7B584C1778CCQ38601876-AAFD3628-5E40-4AAD-B7ED-2EA3CFE87A6BQ38812202-62A07F64-F9E0-4662-A53E-EA916059086EQ39859839-1EB9AC76-AF5A-4897-9205-B3CA497F4494Q40409344-5D0ECEEF-2ED4-40CB-8C21-95696F7DE2DBQ40706767-6EEC1E60-A828-4C03-94D3-844FEA48E7ED
P2860
Hepatitis B: reflections on the current approach to antiviral therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatitis B: reflections on the current approach to antiviral therapy.
@en
Hepatitis B: reflections on the current approach to antiviral therapy.
@nl
type
label
Hepatitis B: reflections on the current approach to antiviral therapy.
@en
Hepatitis B: reflections on the current approach to antiviral therapy.
@nl
prefLabel
Hepatitis B: reflections on the current approach to antiviral therapy.
@en
Hepatitis B: reflections on the current approach to antiviral therapy.
@nl
P1476
Hepatitis B: reflections on the current approach to antiviral therapy
@en
P2093
Robert Perrillo
P356
10.1016/J.JHEP.2008.01.011
P478
48 Suppl 1
P577
2008-02-04T00:00:00Z